Cargando…
The 1,000th Transplant for Multiple Sclerosis and Other Autoimmune Disorders at the HSCT-México Program: A Myriad of Experiences and Knowledge
After gaining experience conducting both auto and allografts in persons with hematological diseases in the HSCT programs in Puebla and Monterrey, México, this study outlines subsequent program autografting patients with autoimmune conditions. The first transplant in multiple sclerosis was conducted...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7937693/ https://www.ncbi.nlm.nih.gov/pubmed/33692748 http://dx.doi.org/10.3389/fneur.2021.647425 |
_version_ | 1783661444446814208 |
---|---|
author | Murrieta-Álvarez, Iván Cantero-Fortiz, Yahveth León-Peña, Andrés A. Olivares-Gazca, Juan C. Priesca-Marín, José Manuel Ruiz-Delgado, Guillermo J. Gómez-De-León, Andrés Gonzalez-Lopez, Elías Eugenio Jaime-Pérez, José Carlos Gómez-Almaguer, David Ruiz-Argüelles, Guillermo J. |
author_facet | Murrieta-Álvarez, Iván Cantero-Fortiz, Yahveth León-Peña, Andrés A. Olivares-Gazca, Juan C. Priesca-Marín, José Manuel Ruiz-Delgado, Guillermo J. Gómez-De-León, Andrés Gonzalez-Lopez, Elías Eugenio Jaime-Pérez, José Carlos Gómez-Almaguer, David Ruiz-Argüelles, Guillermo J. |
author_sort | Murrieta-Álvarez, Iván |
collection | PubMed |
description | After gaining experience conducting both auto and allografts in persons with hematological diseases in the HSCT programs in Puebla and Monterrey, México, this study outlines subsequent program autografting patients with autoimmune conditions. The first transplant in multiple sclerosis was conducted in Puebla on July 5, 2006. From 2015 we increased activity autografting persons with autoimmune conditions in the two campuses of the HSCT-México program: Puebla and Monterrey. By December 6, 2020, patient number 1,000 in the program was autografted. In our experience, a significant reduction in the expanded disability status scale score was achieved in all of the three phenotypes of the disease (from a median of 5.1 to 4.5 points), whereas the response rate (defined as a decrease of at least 0.5 of EDSS score regardless of baseline EDSS, or unchanged EDSS) was 83, 78, and 73% after 12 months in the relapsing-remitting, primary-progressive and secondary-progressive forms of multiple sclerosis, respectively. In addition to analyzing the viability, safety, and efficacy of our method, this study contributes new knowledge to the field of both stem cell transplantation and multiple sclerosis. |
format | Online Article Text |
id | pubmed-7937693 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-79376932021-03-09 The 1,000th Transplant for Multiple Sclerosis and Other Autoimmune Disorders at the HSCT-México Program: A Myriad of Experiences and Knowledge Murrieta-Álvarez, Iván Cantero-Fortiz, Yahveth León-Peña, Andrés A. Olivares-Gazca, Juan C. Priesca-Marín, José Manuel Ruiz-Delgado, Guillermo J. Gómez-De-León, Andrés Gonzalez-Lopez, Elías Eugenio Jaime-Pérez, José Carlos Gómez-Almaguer, David Ruiz-Argüelles, Guillermo J. Front Neurol Neurology After gaining experience conducting both auto and allografts in persons with hematological diseases in the HSCT programs in Puebla and Monterrey, México, this study outlines subsequent program autografting patients with autoimmune conditions. The first transplant in multiple sclerosis was conducted in Puebla on July 5, 2006. From 2015 we increased activity autografting persons with autoimmune conditions in the two campuses of the HSCT-México program: Puebla and Monterrey. By December 6, 2020, patient number 1,000 in the program was autografted. In our experience, a significant reduction in the expanded disability status scale score was achieved in all of the three phenotypes of the disease (from a median of 5.1 to 4.5 points), whereas the response rate (defined as a decrease of at least 0.5 of EDSS score regardless of baseline EDSS, or unchanged EDSS) was 83, 78, and 73% after 12 months in the relapsing-remitting, primary-progressive and secondary-progressive forms of multiple sclerosis, respectively. In addition to analyzing the viability, safety, and efficacy of our method, this study contributes new knowledge to the field of both stem cell transplantation and multiple sclerosis. Frontiers Media S.A. 2021-02-22 /pmc/articles/PMC7937693/ /pubmed/33692748 http://dx.doi.org/10.3389/fneur.2021.647425 Text en Copyright © 2021 Murrieta-Álvarez, Cantero-Fortiz, León-Peña, Olivares-Gazca, Priesca-Marín, Ruiz-Delgado, Gómez-De-León, Gonzalez-Lopez, Jaime-Pérez, Gómez-Almaguer and Ruiz-Argüelles. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Neurology Murrieta-Álvarez, Iván Cantero-Fortiz, Yahveth León-Peña, Andrés A. Olivares-Gazca, Juan C. Priesca-Marín, José Manuel Ruiz-Delgado, Guillermo J. Gómez-De-León, Andrés Gonzalez-Lopez, Elías Eugenio Jaime-Pérez, José Carlos Gómez-Almaguer, David Ruiz-Argüelles, Guillermo J. The 1,000th Transplant for Multiple Sclerosis and Other Autoimmune Disorders at the HSCT-México Program: A Myriad of Experiences and Knowledge |
title | The 1,000th Transplant for Multiple Sclerosis and Other Autoimmune Disorders at the HSCT-México Program: A Myriad of Experiences and Knowledge |
title_full | The 1,000th Transplant for Multiple Sclerosis and Other Autoimmune Disorders at the HSCT-México Program: A Myriad of Experiences and Knowledge |
title_fullStr | The 1,000th Transplant for Multiple Sclerosis and Other Autoimmune Disorders at the HSCT-México Program: A Myriad of Experiences and Knowledge |
title_full_unstemmed | The 1,000th Transplant for Multiple Sclerosis and Other Autoimmune Disorders at the HSCT-México Program: A Myriad of Experiences and Knowledge |
title_short | The 1,000th Transplant for Multiple Sclerosis and Other Autoimmune Disorders at the HSCT-México Program: A Myriad of Experiences and Knowledge |
title_sort | 1,000th transplant for multiple sclerosis and other autoimmune disorders at the hsct-méxico program: a myriad of experiences and knowledge |
topic | Neurology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7937693/ https://www.ncbi.nlm.nih.gov/pubmed/33692748 http://dx.doi.org/10.3389/fneur.2021.647425 |
work_keys_str_mv | AT murrietaalvarezivan the1000thtransplantformultiplesclerosisandotherautoimmunedisordersatthehsctmexicoprogramamyriadofexperiencesandknowledge AT canterofortizyahveth the1000thtransplantformultiplesclerosisandotherautoimmunedisordersatthehsctmexicoprogramamyriadofexperiencesandknowledge AT leonpenaandresa the1000thtransplantformultiplesclerosisandotherautoimmunedisordersatthehsctmexicoprogramamyriadofexperiencesandknowledge AT olivaresgazcajuanc the1000thtransplantformultiplesclerosisandotherautoimmunedisordersatthehsctmexicoprogramamyriadofexperiencesandknowledge AT priescamarinjosemanuel the1000thtransplantformultiplesclerosisandotherautoimmunedisordersatthehsctmexicoprogramamyriadofexperiencesandknowledge AT ruizdelgadoguillermoj the1000thtransplantformultiplesclerosisandotherautoimmunedisordersatthehsctmexicoprogramamyriadofexperiencesandknowledge AT gomezdeleonandres the1000thtransplantformultiplesclerosisandotherautoimmunedisordersatthehsctmexicoprogramamyriadofexperiencesandknowledge AT gonzalezlopezeliaseugenio the1000thtransplantformultiplesclerosisandotherautoimmunedisordersatthehsctmexicoprogramamyriadofexperiencesandknowledge AT jaimeperezjosecarlos the1000thtransplantformultiplesclerosisandotherautoimmunedisordersatthehsctmexicoprogramamyriadofexperiencesandknowledge AT gomezalmaguerdavid the1000thtransplantformultiplesclerosisandotherautoimmunedisordersatthehsctmexicoprogramamyriadofexperiencesandknowledge AT ruizarguellesguillermoj the1000thtransplantformultiplesclerosisandotherautoimmunedisordersatthehsctmexicoprogramamyriadofexperiencesandknowledge AT murrietaalvarezivan 1000thtransplantformultiplesclerosisandotherautoimmunedisordersatthehsctmexicoprogramamyriadofexperiencesandknowledge AT canterofortizyahveth 1000thtransplantformultiplesclerosisandotherautoimmunedisordersatthehsctmexicoprogramamyriadofexperiencesandknowledge AT leonpenaandresa 1000thtransplantformultiplesclerosisandotherautoimmunedisordersatthehsctmexicoprogramamyriadofexperiencesandknowledge AT olivaresgazcajuanc 1000thtransplantformultiplesclerosisandotherautoimmunedisordersatthehsctmexicoprogramamyriadofexperiencesandknowledge AT priescamarinjosemanuel 1000thtransplantformultiplesclerosisandotherautoimmunedisordersatthehsctmexicoprogramamyriadofexperiencesandknowledge AT ruizdelgadoguillermoj 1000thtransplantformultiplesclerosisandotherautoimmunedisordersatthehsctmexicoprogramamyriadofexperiencesandknowledge AT gomezdeleonandres 1000thtransplantformultiplesclerosisandotherautoimmunedisordersatthehsctmexicoprogramamyriadofexperiencesandknowledge AT gonzalezlopezeliaseugenio 1000thtransplantformultiplesclerosisandotherautoimmunedisordersatthehsctmexicoprogramamyriadofexperiencesandknowledge AT jaimeperezjosecarlos 1000thtransplantformultiplesclerosisandotherautoimmunedisordersatthehsctmexicoprogramamyriadofexperiencesandknowledge AT gomezalmaguerdavid 1000thtransplantformultiplesclerosisandotherautoimmunedisordersatthehsctmexicoprogramamyriadofexperiencesandknowledge AT ruizarguellesguillermoj 1000thtransplantformultiplesclerosisandotherautoimmunedisordersatthehsctmexicoprogramamyriadofexperiencesandknowledge |